biotech / news / / Markets Insider
Amgen has an analyst consensus of Moderate Buy, with a price target consensus of $363.33, a 10.16% upside from current levels.
Raymond James assigned a Hold rating to Amgen in a report released yesterday.
KEY POINTS
- Bernstein maintained a Hold rating on Amgen with a $335.00 price target in their latest report.
- Amgen's analyst consensus price target is $363.33, indicating a 10.16% potential upside.
- Amgen reported quarterly revenue of $8.62 billion, up from $8.15 billion the previous year.
COMPANIES
Summarized by Newsio from Markets Insider. How we summarize →